Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo.

Publication ,  Journal Article
Lim, R; Knight, B; Patel, K; McHutchison, JG; Yeoh, GC; Olynyk, JK
Published in: Hepatology
May 2006

Hepatic progenitor cells (called oval cells in rodents) proliferate during chronic liver injury. They have been suggested as targets of malignant transformation in chronic liver diseases, including chronic hepatitis C. Interferon alpha therapy reduces the risk of hepatocellular carcinoma (HCC) in chronic hepatitis C regardless of viral clearance. The aim of this study was to determine whether interferon alpha could reduce the risk of HCC by modifying preneoplastic events in the hepatic progenitor cell population. Pre- and post-treatment liver biopsies were evaluated for changes in t he hepaticprogenitor cell population in 16 patients with non-responding chronic hepatitis C Interferon alpha-based treatment significantly reduced the numbers of c-kit-positive hepatic progenitor cells by 50%. To determine the mechanism of cell number reduction, the effects of interferon alpha on murinehepatic progenitor cells were studied in vitro. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) proliferation assay and proliferating cell nuclear antigen staining showed that interferon alpha had a dose-dependent, anti-proliferative effect Interferon alpha stimulated hepatocytic and biliary differentiation of the oval cell lines reflected by increased expression of albumin and cytokeratin19 accompanied by decreased expression of alphafetoprotein and Thy-1. To validatethese results in vivo, mice were placed on the choline-deficient, ethionine-supplemented diet to induce liver injury and oval cell proliferation and treated with pegylated interferon alpha 2b for 2 weeks. This resulted in a significant four-fold reduction in the number of oval cells (P < .05). In conclusion, interferon alpha-based treatment reduced the number of hepatic progenitor cells in chronic liver injury by modulating apoptosis, proliferation, and differentiation. Supplementay material for this article can

Duke Scholars

Published In

Hepatology

DOI

ISSN

0270-9139

Publication Date

May 2006

Volume

43

Issue

5

Start / End Page

1074 / 1083

Location

United States

Related Subject Headings

  • Stem Cells
  • Recombinant Proteins
  • Polyethylene Glycols
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C, Chronic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lim, R., Knight, B., Patel, K., McHutchison, J. G., Yeoh, G. C., & Olynyk, J. K. (2006). Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology, 43(5), 1074–1083. https://doi.org/10.1002/hep.21170
Lim, Rebecca, Belinda Knight, Keyur Patel, John G. McHutchison, George C. Yeoh, and John K. Olynyk. “Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo.Hepatology 43, no. 5 (May 2006): 1074–83. https://doi.org/10.1002/hep.21170.
Lim R, Knight B, Patel K, McHutchison JG, Yeoh GC, Olynyk JK. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology. 2006 May;43(5):1074–83.
Lim, Rebecca, et al. “Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo.Hepatology, vol. 43, no. 5, May 2006, pp. 1074–83. Pubmed, doi:10.1002/hep.21170.
Lim R, Knight B, Patel K, McHutchison JG, Yeoh GC, Olynyk JK. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology. 2006 May;43(5):1074–1083.
Journal cover image

Published In

Hepatology

DOI

ISSN

0270-9139

Publication Date

May 2006

Volume

43

Issue

5

Start / End Page

1074 / 1083

Location

United States

Related Subject Headings

  • Stem Cells
  • Recombinant Proteins
  • Polyethylene Glycols
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C, Chronic